Biomarker profiling for risk of future heart failure (HFpEF) development

BACKGROUND: The purpose of this study was to investigate the utility of BNP, hsTroponin-I, interleukin-6, sST2, and galectin-3 in predicting the future development of new onset heart failure with preserved ejection fraction (HFpEF) in asymptomatic patients at-risk for HF. METHODS: This is a retrospe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Transl Med
Päätekijät: Watson, Chris J., Gallagher, Joe, Wilkinson, Mark, Russell-Hallinan, Adam, Tea, Isaac, James, Stephanie, O’Reilly, James, O’Connell, Eoin, Zhou, Shuaiwei, Ledwidge, Mark, McDonald, Ken
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871401/
https://ncbi.nlm.nih.gov/pubmed/33563287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02735-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia